Use of a galectin-1-trageted RNAibased approach for the treatment of cancer

Details for Australian Patent Application No. 2006233522 (hide)

Owner Universite Libre de Bruxelles Universite Catholique De Louvain

Inventors Henriet, Patrick; Courtoy, Pierre; Camby, Isabelle; Lefranc, Florence; Kiss, Robert

Agent Shelston IP

Pub. Number AU-A-2006233522

PCT Pub. Number WO2006/108474

Priority 60/670,334 12.04.05 US

Filing date 9 March 2006

Wipo publication date 19 October 2006

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/108474 Priority application(s): WO2006/108474

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006233523-Liquid hard surface cleaning composition

2006233513-Lossless encoding of information with guaranteed maximum bitrate